2023 Partners

reaction

Reaction Biology

Lead Partner

Our clients are seeking answers in their quest to discover effective
treatments for patients. Finding these answers is our mission as a CRO. Our
method is to accelerate the drug discovery process with the widest possible
range of assays and services but also to maintain an integrated view of
the journey to a lead drug candidate. We strive to provide excellent data,
delivered in a timely, collaborative manner by outstanding scientists. Who
are we? We’re your partner.

www.reactionbiology.com

site-logo

AssayQuant Technologies

Expertise Partner

AssayQuant’s mission is to support the development of more effective
therapies for cancer, chronic inflammation, neurodegeneration, and other
serious conditions. Our team is motivated by a shared vision of reducing
suffering, to build a healthier world. We stand with you at the frontier of
target biology and drug discovery & development, helping you to rapidly and
effectively identify the best solutions, from the vast number of possibilities.

www.assayquant.com

Promega-Logo-for-web

Promega

Expertise Partner

We share your passion for science. Promega is a global leader in providing
innovative solutions and technical support to life scientists in academic,
industrial and government settings. Promega products are used by life
scientists who are asking fundamental questions about biological processes
as well as by scientists who are applying scientific knowledge to diagnose
and treat diseases, discover new therapeutics, and use genetics and DNA
testing for human identification. Let’s collaborate.

www.promega.co.uk

enzymlogic-logo-rgb

Enzymlogic

Innvoation Partner

Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery. We focus on the Hit to Lead (H2L) and Lead Optimization (LO) stages of drug discovery where our optimized kinetic profiling assays identify compounds with therapeutic potential that merit further progression into clinical trials.

www.enzymlogic.com